Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 231

1.

Loss of Wilms tumor 1 protein is a marker for apoptosis in response to replicative stress in leukemic cells.

Pons M, Reichardt CM, Hennig D, Nathan A, Kiweler N, Stocking C, Wichmann C, Christmann M, Butter F, Reichardt S, Schneider G, Heinzel T, Englert C, Hartkamp J, Krämer OH, Mahendrarajah N.

Arch Toxicol. 2018 Mar 27. doi: 10.1007/s00204-018-2202-3. [Epub ahead of print]

PMID:
29589053
2.

SHIP1, but not an AML-derived SHIP1 mutant, suppresses myeloid leukemia growth in a xenotransplantation mouse model.

Täger M, Horn S, Latuske E, Ehm P, Schaks M, Nalaskowski M, Fehse B, Fiedler W, Stocking C, Wellbrock J, Jücker M.

Gene Ther. 2017 Nov;24(11):749-753. doi: 10.1038/gt.2017.88. Epub 2017 Nov 16.

PMID:
29143813
3.

Vagus Nerve Stimulation Paired with Tones for the Treatment of Tinnitus: A Prospective Randomized Double-blind Controlled Pilot Study in Humans.

Tyler R, Cacace A, Stocking C, Tarver B, Engineer N, Martin J, Deshpande A, Stecker N, Pereira M, Kilgard M, Burress C, Pierce D, Rennaker R, Vanneste S.

Sci Rep. 2017 Sep 20;7(1):11960. doi: 10.1038/s41598-017-12178-w.

4.

Synergistic suppression of t(8;21)-positive leukemia cell growth by combining oridonin and MAPK1/ERK2 inhibitors.

Spirin P, Lebedev T, Orlova N, Morozov A, Poymenova N, Dmitriev SE, Buzdin A, Stocking C, Kovalchuk O, Prassolov V.

Oncotarget. 2017 Jun 16;8(34):56991-57002. doi: 10.18632/oncotarget.18503. eCollection 2017 Aug 22.

5.

Impact of Molecular Genetics on Outcome in Myelofibrosis Patients after Allogeneic Stem Cell Transplantation.

Kröger N, Panagiota V, Badbaran A, Zabelina T, Triviai I, Araujo Cruz MM, Shahswar R, Ayuk F, Gehlhaar M, Wolschke C, Bollin R, Walter C, Dugas M, Wiehlmann L, Lehmann U, Koenecke C, Chaturvedi A, Alchalby H, Stadler M, Eder M, Christopeit M, Göhring G, Koenigsmann M, Schlegelberger B, Kreipe HH, Ganser A, Stocking C, Fehse B, Thol F, Heuser M.

Biol Blood Marrow Transplant. 2017 Jul;23(7):1095-1101. doi: 10.1016/j.bbmt.2017.03.034. Epub 2017 Apr 4.

PMID:
28389256
6.

RUNX1 cooperates with FLT3-ITD to induce leukemia.

Behrens K, Maul K, Tekin N, Kriebitzsch N, Indenbirken D, Prassolov V, Müller U, Serve H, Cammenga J, Stocking C.

J Exp Med. 2017 Mar 6;214(3):737-752. doi: 10.1084/jem.20160927. Epub 2017 Feb 17.

7.

Diagnosis and relapse: cytogenetically normal acute myelogenous leukemia without FLT3-ITD or MLL-PTD.

Chien W, Sun QY, Ding LW, Mayakonda A, Takao S, Liu L, Lim SL, Tan KT, Garg M, De Sousa Maria Varela A, Xiao J, Jacob N, Behrens K, Stocking C, Lill M, Madan V, Hattori N, Gery S, Ogawa S, Wakita S, Ikezoe T, Shih LY, Alpermann T, Haferlach T, Yang H, Koeffler HP.

Leukemia. 2017 Mar;31(3):762-766. doi: 10.1038/leu.2016.343. Epub 2016 Nov 24. No abstract available.

PMID:
27881871
8.

Preliminary data on precision of QuantiFERON-TB Plus performance.

Gallagher D, Manissero D, Stocking C, Pyne C.

Eur Respir J. 2016 Sep;48(3):953-4. doi: 10.1183/13993003.00596-2016. No abstract available.

9.

Runx1 downregulates stem cell and megakaryocytic transcription programs that support niche interactions.

Behrens K, Triviai I, Schwieger M, Tekin N, Alawi M, Spohn M, Indenbirken D, Ziegler M, Müller U, Alexander WS, Stocking C.

Blood. 2016 Jun 30;127(26):3369-81. doi: 10.1182/blood-2015-09-668129. Epub 2016 Apr 13.

10.

Essential control of early B-cell development by Mef2 transcription factors.

Herglotz J, Unrau L, Hauschildt F, Fischer M, Kriebitzsch N, Alawi M, Indenbirken D, Spohn M, Müller U, Ziegler M, Schuh W, Jäck HM, Stocking C.

Blood. 2016 Feb 4;127(5):572-81. doi: 10.1182/blood-2015-04-643270. Epub 2015 Dec 10.

11.

RUNX1 represses the erythroid gene expression program during megakaryocytic differentiation.

Kuvardina ON, Herglotz J, Kolodziej S, Kohrs N, Herkt S, Wojcik B, Oellerich T, Corso J, Behrens K, Kumar A, Hussong H, Urlaub H, Koch J, Serve H, Bonig H, Stocking C, Rieger MA, Lausen J.

Blood. 2015 Jun 4;125(23):3570-9. doi: 10.1182/blood-2014-11-610519. Epub 2015 Apr 24.

12.

[Universal modular system for in vitro screening of potential inhibitors of HIV-1 replication].

Prokof'eva MM, Orlova NN, Gornostaeva AS, Shul'gin AA, Nikitenko NA, Senchenko VN, Lebedev TD, Spirin PV, Riechen K, Fehse B, Stocking C, Prasolov VS.

Mol Biol (Mosk). 2014 Mar-Apr;48(2):344-8. Russian.

13.

CD133 marks a stem cell population that drives human primary myelofibrosis.

Triviai I, Stübig T, Niebuhr B, Hussein K, Tsiftsoglou A, Fehse B, Stocking C, Kröger N.

Haematologica. 2015 Jun;100(6):768-79. doi: 10.3324/haematol.2014.118463. Epub 2015 Feb 27.

14.

Ebola virus disease in mice with transplanted human hematopoietic stem cells.

Lüdtke A, Oestereich L, Ruibal P, Wurr S, Pallasch E, Bockholt S, Ip WH, Rieger T, Gómez-Medina S, Stocking C, Rodríguez E, Günther S, Muñoz-Fontela C.

J Virol. 2015 Apr;89(8):4700-4. doi: 10.1128/JVI.03546-14. Epub 2015 Feb 11.

15.

Amplitude modulated S-tones can be superior to noise for tinnitus reduction.

Tyler R, Stocking C, Secor C, Slattery WH 3rd.

Am J Audiol. 2014 Sep;23(3):303-8. doi: 10.1044/2014_AJA-14-0009.

PMID:
25026936
16.

Endogenous retrovirus induces leukemia in a xenograft mouse model for primary myelofibrosis.

Triviai I, Ziegler M, Bergholz U, Oler AJ, Stübig T, Prassolov V, Fehse B, Kozak CA, Kröger N, Stocking C.

Proc Natl Acad Sci U S A. 2014 Jun 10;111(23):8595-600. doi: 10.1073/pnas.1401215111. Epub 2014 May 27.

17.

Silencing AML1-ETO gene expression leads to simultaneous activation of both pro-apoptotic and proliferation signaling.

Spirin PV, Lebedev TD, Orlova NN, Gornostaeva AS, Prokofjeva MM, Nikitenko NA, Dmitriev SE, Buzdin AA, Borisov NM, Aliper AM, Garazha AV, Rubtsov PM, Stocking C, Prassolov VS.

Leukemia. 2014 Nov;28(11):2222-8. doi: 10.1038/leu.2014.130. Epub 2014 Apr 14.

PMID:
24727677
18.

Cooperativity of RUNX1 and CSF3R mutations in severe congenital neutropenia: a unique pathway in myeloid leukemogenesis.

Skokowa J, Steinemann D, Katsman-Kuipers JE, Zeidler C, Klimenkova O, Klimiankou M, Unalan M, Kandabarau S, Makaryan V, Beekman R, Behrens K, Stocking C, Obenauer J, Schnittger S, Kohlmann A, Valkhof MG, Hoogenboezem R, Göhring G, Reinhardt D, Schlegelberger B, Stanulla M, Vandenberghe P, Donadieu J, Zwaan CM, Touw IP, van den Heuvel-Eibrink MM, Dale DC, Welte K.

Blood. 2014 Apr 3;123(14):2229-37. doi: 10.1182/blood-2013-11-538025. Epub 2014 Feb 12.

19.

Aberrant ZNF423 impedes B cell differentiation and is linked to adverse outcome of ETV6-RUNX1 negative B precursor acute lymphoblastic leukemia.

Harder L, Eschenburg G, Zech A, Kriebitzsch N, Otto B, Streichert T, Behlich AS, Dierck K, Klingler B, Hansen A, Stanulla M, Zimmermann M, Kremmer E, Stocking C, Horstmann MA.

J Exp Med. 2013 Oct 21;210(11):2289-304. doi: 10.1084/jem.20130497. Epub 2013 Sep 30.

20.

[Expression of FLT3-ITD oncogene confers mice progenitor B-cells BAF3 sensitivity to the ribonuclease binase cytotoxic action].

Mit'kevich VA, Orlova NN, Petrushanko IIu, Simonenko OV, Spirin PV, Prokofeva MM, Gornostaeva AS, Stocking C, Makarov AA, Prasolov VS.

Mol Biol (Mosk). 2013 Mar-Apr;47(2):282-5. Russian.

21.

Runx1 is essential at two stages of early murine B-cell development.

Niebuhr B, Kriebitzsch N, Fischer M, Behrens K, Günther T, Alawi M, Bergholz U, Müller U, Roscher S, Ziegler M, Buchholz F, Grundhoff A, Stocking C.

Blood. 2013 Jul 18;122(3):413-23. doi: 10.1182/blood-2013-01-480244. Epub 2013 May 23.

22.

PU.1 level-directed chromatin structure remodeling at the Irf8 gene drives dendritic cell commitment.

Schönheit J, Kuhl C, Gebhardt ML, Klett FF, Riemke P, Scheller M, Huang G, Naumann R, Leutz A, Stocking C, Priller J, Andrade-Navarro MA, Rosenbauer F.

Cell Rep. 2013 May 30;3(5):1617-28. doi: 10.1016/j.celrep.2013.04.007. Epub 2013 Apr 25.

23.

A new system for parallel drug screening against multiple-resistant HIV mutants based on lentiviral self-inactivating (SIN) vectors and multi-colour analyses.

Prokofjeva MM, Riecken K, Spirin PV, Yanvarév DV, Düsedau A, Ellinger B, Fehse B, Stocking C, Prassolov VS.

AIDS Res Ther. 2013 Jan 3;10(1):1. doi: 10.1186/1742-6405-10-1.

24.

A microRNA encoded by Kaposi sarcoma-associated herpesvirus promotes B-cell expansion in vivo.

Dahlke C, Maul K, Christalla T, Walz N, Schult P, Stocking C, Grundhoff A.

PLoS One. 2012;7(11):e49435. doi: 10.1371/journal.pone.0049435. Epub 2012 Nov 20.

25.

Protease-sensitive prion species in neoplastic spleens of prion-infected mice with uncoupling of PrP(Sc) and prion infectivity.

Krasemann S, Neumann M, Szalay B, Stocking C, Glatzel M.

J Gen Virol. 2013 Feb;94(Pt 2):453-63. doi: 10.1099/vir.0.045922-0. Epub 2012 Nov 7.

PMID:
23136363
26.

Adaptor protein Lnk binds to and inhibits normal and leukemic FLT3.

Lin DC, Yin T, Koren-Michowitz M, Ding LW, Gueller S, Gery S, Tabayashi T, Bergholz U, Kazi JU, Rönnstrand L, Stocking C, Koeffler HP.

Blood. 2012 Oct 18;120(16):3310-7. doi: 10.1182/blood-2011-10-388611. Epub 2012 Aug 31.

27.

[Replication-competent γ-retrovirus Mo-MuLV expressing green fluorescent protein gene as an efficient tool for screening of inhibitors of retroviruses that use heparan sulfate as the primary cell receptor].

Stepanov OA, Prokof'eva MM, Stocking C, Varlamov VP, Levov AN, Vikhoreva GA, Spirin PV, Mikhaĭlov SN, Prasolov VS.

Mol Biol (Mosk). 2012 May-Jun;46(3):508-18. Russian.

PMID:
22888640
28.

Screening of Potential HIV-1 Inhibitors/Replication Blockers Using Secure Lentiviral in Vitro System.

Prokofjeva MM, Spirin PV, Yanvarev DV, Ivanov AV, Novikov MS, Stepanov OA, Gottikh MB, Kochetkov SN, Fehse B, Stocking C, Prassolov VS.

Acta Naturae. 2011 Oct;3(4):55-65.

29.

Polycomb group ring finger 1 cooperates with Runx1 in regulating differentiation and self-renewal of hematopoietic cells.

Ross K, Sedello AK, Todd GP, Paszkowski-Rogacz M, Bird AW, Ding L, Grinenko T, Behrens K, Hubner N, Mann M, Waskow C, Stocking C, Buchholz F.

Blood. 2012 May 3;119(18):4152-61. doi: 10.1182/blood-2011-09-382390. Epub 2012 Mar 12.

30.

[Modulation of activated oncogene c-kit expression with RNA-interference].

Spirin PV, Nikitenko NA, Lebedev TD, Rubtsov PM, Stocking C, Prasolov VS.

Mol Biol (Mosk). 2011 Nov-Dec;45(6):1036-45. Russian.

PMID:
22295574
31.

Persistent retroviral infection with MoMuLV influences neuropathological signature and phenotype of prion disease.

Krasemann S, Neumann M, Luepke JP, Grashorn J, Wurr S, Stocking C, Glatzel M.

Acta Neuropathol. 2012 Jul;124(1):111-26. doi: 10.1007/s00401-012-0944-1. Epub 2012 Jan 24.

PMID:
22271154
32.

The symptom experience of community-dwelling persons with dementia: self and caregiver report and comparison with standardized symptom assessment measures.

Murray TM, Sachs GA, Stocking C, Shega JW.

Am J Geriatr Psychiatry. 2012 Apr;20(4):298-305. doi: 10.1097/JGP.0b013e318235b758.

33.

RGB marking facilitates multicolor clonal cell tracking.

Weber K, Thomaschewski M, Warlich M, Volz T, Cornils K, Niebuhr B, Täger M, Lütgehetmann M, Pollok JM, Stocking C, Dandri M, Benten D, Fehse B.

Nat Med. 2011 Apr;17(4):504-9. doi: 10.1038/nm.2338. Epub 2011 Mar 27.

PMID:
21441917
34.

AML1/ETO induces self-renewal in hematopoietic progenitor cells via the Groucho-related amino-terminal AES protein.

Steffen B, Knop M, Bergholz U, Vakhrusheva O, Rode M, Köhler G, Henrichs MP, Bulk E, Hehn S, Stehling M, Dugas M, Bäumer N, Tschanter P, Brandts C, Koschmieder S, Berdel WE, Serve H, Stocking C, Müller-Tidow C.

Blood. 2011 Apr 21;117(16):4328-37. doi: 10.1182/blood-2009-09-242545. Epub 2011 Jan 18.

35.

Cell and virus genetics at the roots of gene therapy, retrovirology, and hematopoietic stem cell biology: Wolfram Ostertag (1937-2010).

Stocking C, Grez M, Fehse B, von Laer D, Itoh K, Prassolov V, Nowock J, Kühlcke K, Just U, Schröder T, Klump H, Schiedlmeier B, Grassman E, Meyer J, Li Z, Schambach A, Modlich U, Kustikova O, Galla M, Bode J, Zander A, Baum C.

Hum Gene Ther. 2010 Nov;21(11):1501-3. doi: 10.1089/hum.2010.1901. No abstract available.

PMID:
21091034
36.

[Downregulation of activated leukemic oncogenes AML1-ETO and RUNX1(K83N) expression with RNA-interference].

Spirin PV, Baskaran F, Orlova NN, Rulina AV, Nikitenko NA, Chernolovskaia EL, Zenkova MA, Vlasov VV, Rubtsov PM, Chumakov PM, Stocking C, Prasolov VS.

Mol Biol (Mosk). 2010 Sep-Oct;44(5):876-88. Russian.

PMID:
21090242
37.

Caspase 3 activity in whole cell extracts of Ba/F3 cells is unrelated to apoptosis.

Speidel D, Stocking C.

Cell Cycle. 2010 Sep 15;9(18):3823-5. Epub 2010 Sep 25. No abstract available.

PMID:
20855972
38.

Pim2 cooperates with PML-RARalpha to induce acute myeloid leukemia in a bone marrow transplantation model.

Agrawal-Singh S, Koschmieder S, Gelsing S, Stocking C, Stehling M, Thiede C, Thoennissen NH, Köhler G, Valk PJ, Delwel R, Mills K, Bäumer N, Tickenbrock L, Hansen K, Berdel WE, Müller-Tidow C, Serve H.

Blood. 2010 Jun 3;115(22):4507-16. doi: 10.1182/blood-2009-03-210070. Epub 2010 Mar 9.

39.

Host range and cellular tropism of the human exogenous gammaretrovirus XMRV.

Stieler K, Schulz C, Lavanya M, Aepfelbacher M, Stocking C, Fischer N.

Virology. 2010 Mar 30;399(1):23-30. doi: 10.1016/j.virol.2009.12.028. Epub 2010 Jan 27.

40.

Immunologic hurdles of therapeutic stem cell transplantation.

Utermöhlen O, Baschuk N, Abdullah Z, Engelmann A, Siebolts U, Wickenhauser C, Stocking C, Krönke M.

Biol Chem. 2009 Oct;390(10):977-83. doi: 10.1515/BC.2009.114. Review.

PMID:
19642871
41.

Homing and invasiveness of MLL/ENL leukemic cells is regulated by MEF2C.

Schwieger M, Schüler A, Forster M, Engelmann A, Arnold MA, Delwel R, Valk PJ, Löhler J, Slany RK, Olson EN, Stocking C.

Blood. 2009 Sep 17;114(12):2476-88. doi: 10.1182/blood-2008-05-158196. Epub 2009 Jul 7.

42.

RUNX1 and its fusion oncoprotein derivative, RUNX1-ETO, induce senescence-like growth arrest independently of replicative stress.

Wolyniec K, Wotton S, Kilbey A, Jenkins A, Terry A, Peters G, Stocking C, Cameron E, Neil JC.

Oncogene. 2009 Jul 9;28(27):2502-12. doi: 10.1038/onc.2009.101. Epub 2009 May 18.

43.

Head, Neck, and Eye Movements That Modulate Tinnitus.

Simmons R, Dambra C, Lobarinas E, Stocking C, Salvi R.

Semin Hear. 2008 Nov;29(4):361-370.

44.

Reduced proliferation of CD34(+) cells from patients with acute myeloid leukemia after gene transfer of INPP5D.

Metzner A, Precht C, Fehse B, Fiedler W, Stocking C, Günther A, Mayr GW, Jücker M.

Gene Ther. 2009 Apr;16(4):570-3. doi: 10.1038/gt.2008.184. Epub 2009 Jan 15.

PMID:
19148132
45.

Variable judgments of decisional capacity in cognitively impaired research subjects.

Stocking CB, Hougham GW, Danner DD, Patterson MB, Whitehouse PJ, Sachs GA.

J Am Geriatr Soc. 2008 Oct;56(10):1893-7. doi: 10.1111/j.1532-5415.2008.01922.x.

46.

Investigation of C/EBPalpha function in human (versus murine) myelopoiesis provides novel insight into the impact of CEBPA mutations in acute myelogenous leukemia (AML).

Niebuhr B, Iwanski GB, Schwieger M, Roscher S, Stocking C, Cammenga J.

Leukemia. 2009 May;23(5):978-83. doi: 10.1038/leu.2008.332. Epub 2008 Nov 20. No abstract available.

PMID:
19020539
47.

Murine endogenous retroviruses.

Stocking C, Kozak CA.

Cell Mol Life Sci. 2008 Nov;65(21):3383-98. doi: 10.1007/s00018-008-8497-0. Review.

48.

Cloning of genes involved in chromosomal translocations by high-resolution single nucleotide polymorphism genomic microarray.

Kawamata N, Ogawa S, Zimmermann M, Niebuhr B, Stocking C, Sanada M, Hemminki K, Yamatomo G, Nannya Y, Koehler R, Flohr T, Miller CW, Harbott J, Ludwig WD, Stanulla M, Schrappe M, Bartram CR, Koeffler HP.

Proc Natl Acad Sci U S A. 2008 Aug 19;105(33):11921-6. doi: 10.1073/pnas.0711039105. Epub 2008 Aug 12.

49.

Identification of the myelin protein plasmolipin as the cell entry receptor for Mus caroli endogenous retrovirus.

Miller AD, Bergholz U, Ziegler M, Stocking C.

J Virol. 2008 Jul;82(14):6862-8. doi: 10.1128/JVI.00397-08. Epub 2008 May 7.

50.

Overexpression of the p85alpha regulatory subunit of phosphatidylinositol 3-kinase inhibits GM-CSF-dependent colony formation of CD34+ hematopoietic progenitor cells.

Hoxha E, Fehse B, Ortmeyer G, Stocking C, Mayr GW, Jücker M.

Leuk Lymphoma. 2008 Jun;49(6):1206-8. doi: 10.1080/10428190801993496. No abstract available.

PMID:
18452100

Supplemental Content

Loading ...
Support Center